NCT05987605 2025-02-19Phase I/II Clinical Study of 1A46 Drug SubstanceBioRay Pharmaceutical Co., Ltd.Phase 1 Terminated4 enrolled
NCT00724425 2015-04-15A Phase 1 Dose Escalation Study of IPI-493Infinity Pharmaceuticals, Inc.Phase 1 Terminated53 enrolled